CellProthera

CELLPROTHERA IS ONE OF THE MOST PROMISING EUROPEAN STEM CELL-FOCUSED BIOTECHS.

It has developed a revolutionary post-infarct heart-regenerative therapy based on the injection of adult autologous CD34+ stem cells. CellProthera is currently finalizing a Phase II multicenter (France & UK) randomized clinical trial over 44 patients.